期刊
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
卷 33, 期 3, 页码 472-486出版社
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2021101293
关键词
acute kidney injury; ferroptosis; necroptosis; cell death; necroinflammation; acute tubular necrosis; nephron loss
Understanding the mechanisms of nephron loss is crucial for preventing the progression of chronic kidney disease. The death of renal tubular cells can occur through apoptosis or necrosis, leading to different types of cell death and inflammatory responses in different pathological processes. A detailed understanding of the mechanisms of cell death and inflammatory responses during tubular necrosis can inform therapeutic options.
Understanding nephron loss is a primary strategy for preventing CKD progression. Death of renal tubular cells may occur by apoptosis during developmental and regenerative processes. However, during AKI, the transition of AKI to CKD, sepsis-associated AKI, and kidney transplantation ferroptosis and necroptosis, two pathways associated with the loss of plasma membrane integrity, kill renal cells. This necrotic type of cell death is associated with an inflammatory response, which is referred to as necroinflammation. Importantly, the necroinflammatory response to cells that die by necroptosis may be fundamentally different from the tissue response to ferroptosis. Although mechanisms of ferroptosis and necroptosis have recently been investigated in detail, the cell death propagation during tubular necrosis, although described morphologically, remains incompletely understood. Here, we argue that a molecular switch downstream of tubular necrosis determines nephron regeneration versus nephron loss. Unraveling the details of this ?switch? must include the inflammatory response to tubular necrosis and regenerative signals potentially controlled by inflammatory cells, including the stimulation of myofibroblasts as the origin of fibrosis. Understanding in detail the molecular switch and the inflammatory responses to tubular necrosis can inform the discussion of therapeutic options.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据